CIK: 1377952 - Address: C/O Zentalis Pharmaceuticals, Inc., 1359 Broadway, Suite 1710, New York, NY 10018
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112-2-44-7-17-38-11
P%wins505010000033

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/25/20 20:34
4/7/20
ZNTLZentalis Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDOP,CEOP1618.000103,094D
1/29/15 17:09
1/27/15
VSARVersartis, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDP2,50117.25414572,140I-14-6-4-16-36-4-87-6-2-43
3/27/14 18:36
3/26/14
VSARVersartis, Inc.DEHealthDrugPharmaceutical PreparationsSun Anthony YNYDTP.d1,26021.00336031,995I-2000-7-32-33

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact